Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Harmonization of alcohol use data and mortality across a multi-national HIV cohort collaboration.
Ingle SM, Trickey A, Lankina A, McGinnis KA, Justice A, Cavassini M, d' Arminio Monforte A, van Sighem A, Gill MJ, Crane HM, Obel N, Jarrin I, Wallner E, Guest J, Silverberg MJ, Vourli G, Wittkop L, Sterling TR, Satre DD, Burkholder GA, Costagliola D, Sterne JAC. Ingle SM, et al. Among authors: d arminio monforte a. Alcohol Clin Exp Res (Hoboken). 2025 Jan 8. doi: 10.1111/acer.15522. Online ahead of print. Alcohol Clin Exp Res (Hoboken). 2025. PMID: 39779221
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic.
Vergori A, Gianotti N, Tavelli A, Tincati C, Giacomelli A, Matteini E, Lapadula G, Taramasso L, Sarmati L, D'Arminio Monforte A, Antinori A, Cozzi-Lepri A, On Behalf Of The Icona Foundation Study; ICONA Foundation Study. Vergori A, et al. Among authors: d arminio monforte a. Viruses. 2024 Nov 23;16(12):1822. doi: 10.3390/v16121822. Viruses. 2024. PMID: 39772133 Free PMC article.
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohort.
d'Arminio Monforte A, Tavelli A, Quiros-Roldan E, Fabbiani M, Ferrara M, Lo Caputo S, Squillace N, Rusconi S, Ponzano M, Bovis F, Antinori A, Saracino A, Cozzi-Lepri A. d'Arminio Monforte A, et al. HIV Med. 2024 Dec 2. doi: 10.1111/hiv.13740. Online ahead of print. HIV Med. 2024. PMID: 39618291
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort.
Soria A, Graziano F, Ghilardi G, Lapadula G, Gasperina DD, Benatti SV, Quiros-Roldan E, Milesi M, Bai F, Merli M, Minisci D, Franzetti M, Asperges E, Chiabrando F, Pocaterra D, Pandolfo A, Zanini F, Lombardi D, Cappelletti A, Rugova A, Borghesi ML, Squillace N, Pusterla L, Piconi S, Morelli P, Querini PR, Bruno R, Rusconi S, Casari S, Bandera A, Franzetti F, Travi G, D'Arminio Monforte A, Marchetti G, Pan A, Castelli F, Rizzi M, Dentali F, Mallardo M, Rossi E, Valsecchi MG, Galimberti S, Bonfanti P. Soria A, et al. Among authors: d arminio monforte a. Heliyon. 2024 Aug 13;10(16):e36102. doi: 10.1016/j.heliyon.2024.e36102. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39247344 Free PMC article.
Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year.
Esser S, Inciarte A, Levy I, D'Arminio Monforte A, Lambert JS, van Welzen B, Teruya K, Boffito M, Liu CE, Aydın OA, Thorpe D, Heinzkill M, Marongiu A, Cassidy T, Haubrich R, D'Amato L, Robineau O. Esser S, et al. Among authors: d arminio monforte a. Future Microbiol. 2024;19(15):1273-1282. doi: 10.1080/17460913.2024.2391190. Epub 2024 Sep 4. Future Microbiol. 2024. PMID: 39229785 Free PMC article.
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.
Cingolani A, Tavelli A, De Benedittis S, Mastrorosa I, Muccini C, Bini T, Carraro A, Compagno M, Mazzitelli M, Guastavigna M, Cernuschi M, Torti C, Antinori A, d'Arminio Monforte A; ICONA Foundation Study group. Cingolani A, et al. Among authors: d arminio monforte a. J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273. J Antimicrob Chemother. 2024. PMID: 39140512
IAPAC-Lancet HIV Commission on the future of urban HIV responses.
Zuniga JM, Prachniak C, Policek N, Magula N, Gandhi A, Anderson J, Diallo DD, Lima VD, Ravishankar S, Acharya S, Achrekar A, Adeleke M, Aïna É, Baptiste S, Barrow G, Begovac J, Bukusi E, Castel A, Castellanos E, Cestou J, Chirambo G, Crowley J, Dedes N, Ditiu L, Doherty M, Duncombe C, Durán A, Futterman D, Hader S, Kounkeu C, Lawless F, Lazarus JV, Lex S, Lobos C, Mayer K, Mejia M, Moheno HR, d'Arminio Monforte A, Morán-Arribas M, Nagel D, Ndugwa R, Ngunu C, Poonkasetwattana M, Prins M, Quesada A, Rudnieva O, Ruth S, Saavedra J, Toma L, Wanjiku Njenga L, Williams B. Zuniga JM, et al. Among authors: d arminio monforte a. Lancet HIV. 2024 Sep;11(9):e607-e648. doi: 10.1016/S2352-3018(24)00124-3. Epub 2024 Jul 20. Lancet HIV. 2024. PMID: 39043198 Review. No abstract available.
Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV.
Roen AO, Peters L, Wandeler G, van der Valk M, Zangerle R, Günthard HF, Wit F, Mussini C, De Wit S, d'Arminio Monforte A, Vehreschild JJ, Castagna A, Jaschinski N, Vannappagari V, Chen L, Tallada J, C'mar J, Mocroft A, Ryom L. Roen AO, et al. Among authors: d arminio monforte a. Open Forum Infect Dis. 2024 Jun 8;11(6):ofae308. doi: 10.1093/ofid/ofae308. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38919512 Free PMC article.
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.
Hutchinson J, Neesgard B, Kowalska J, Grabmeier-Pfistershammer K, Johnson M, Kusejko K, De Wit S, Wit F, Mussini C, Castagna A, Stecher M, Pradier C, Domingo P, Carlander C, Wasmuth J, Chkhartishvili N, Uzdaviniene V, Haberl A, d'Arminio Monforte A, Garges H, Gallant J, Said M, Schmied B, van der Valk M, Konopnicki D, Jaschinski N, Mocroft A, Greenberg L, Burns F, Ryom L, Petoumenos K. Hutchinson J, et al. Among authors: d arminio monforte a. HIV Med. 2024 Sep;25(9):1058-1074. doi: 10.1111/hiv.13662. Epub 2024 Jun 5. HIV Med. 2024. PMID: 38840507
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy.
Malagnino V, Cozzi-Lepri A, Svicher V, Girardi E, Perno CF, Saracino A, Cuomo G, Rusconi S, Puoti M, D'Arminio Monforte A, Andreoni M, Sarmati L; ICONA Foundation Study Group. Malagnino V, et al. Among authors: d arminio monforte a. HIV Med. 2024 Oct;25(10):1101-1111. doi: 10.1111/hiv.13680. Epub 2024 Jun 4. HIV Med. 2024. PMID: 38837593
593 results